Clinical Trials

Showing trials with last updates posted in 2026.

NCT01989585 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
75 participants

Testing the Addition of Navitoclax to the Combination of Dabrafenib and Trametinib in People Who Have BRAF Mutant Melanoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2014-03-24
Completion:
2027-12-31
Conditions
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • Malignant Solid Neoplasm
  • Metastatic Melanoma
  • Unresectable Melanoma
Interventions
  • PROCEDURE
  • DRUG
  • OTHER
  • BIOLOGICAL
No Results Yet
NCT07756489 | NOT_YET_RECRUITING | NA
65 participants

SECURE Post-Market Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-10
Start Date:
2026-10-31
Completion:
2028-04-30
Conditions
  • Acute Peripheral Nerve Injuries
  • Digital Nerve Injury
Interventions
  • DEVICE
No Results Yet
NCT07756177 | ACTIVE_NOT_RECRUITING
200 participants

Guangzhou Preterm and Term Birth Cohort Study

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-10
Start Date:
2023-11-21
Completion:
2026-12-31
Conditions
  • Preterm Birth
  • Neurodevelopmental Disorders
  • Overweight
  • Obesity
  • Allergic Diseases
Interventions
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page